Niagen Bioscience, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-11.4M | $-2.9M | $-5.4M | $-4.4M | $-11.7M | $-7.9M |
| Depreciation & Amortization | $510.0K | $332.0K | $223.0K | $246.0K | — | — |
| Depreciation | $510.0K | $331.7K | $222.7K | $246.2K | $328.1K | $328.6K |
| Amortization | $206.0K | $87.8K | $35.6K | $23.5K | $15.9K | $70.2K |
| Stock-Based Compensation | $4.6M | $1.2M | $2.9M | $1.3M | $2.7M | $3.0M |
| Net Cash from Operating Activities | $-9.8M | $-2.9M | $-2.6M | $-3.9M | $-10.1M | $-4.1M |
| Investing Activities | ||||||
| Capital Expenditures | $1.2M | $1.5M | $123.1K | $137.3K | $24.6K | $150.7K |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $4.6M | $-1.7M | $1.6M | $998.7K | $-76.6K | $-176.7K |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | $0 | — | — | — | $-8.2K | — |
| Net Cash from Financing Activities | $48.9M | $754.3K | $2.7M | $4.6M | $10.3M | $2.5M |
| Net Change in Cash | $43.7M | $-3.9M | $1.7M | $1.7M | $99.8K | $-1.8M |
| Free Cash Flow | $-11.0M | $-4.4M | $-2.7M | $-4.0M | $-10.1M | $-4.2M |